ARTICLE SUMMARY:
Analytics 4 Life has been stealthy until recently, but on the eve of the completion of its clinical trial has unveiled a new modality that uses AI to measure disease, one that makes sense of electrical signals that can be measured non-invasively. The company’s target application—coronary artery disease—checks off all the boxes of qualities required for the success of a disruptive and valuable application of AI, including a large clinical need, and a machine-learning application.
Artificial intelligence (AI) is one of the most exciting new technologies applied in the healthcare industry today.
